Taken together, our findings reveal that exosomes derived from rats with OSA increase the risk of hepatic steatosis in MASLD by regulating the expression of TCONS_00039830/miR-455-3p/Smad2 in hepatocytes. The gene discussed is SMAD2; the disease is metabolic dysfunction-associated steatotic liver disease.